McIntosh I H, Thynne G S, Bejrajati P, Walsh G, Greening W P
Dev Biol Stand. 1977;38:477-82.
A Phase I study of an immuno-chemotherapy regime was carried out using C. parvum as an immune-modulator. 14 women were studied. All received doses of C. parvum ranging from 2.5 mg to 21 mg administered in 1 litre of dextrose saline over 4 h. No evidence of tumour enhancement was observed.
开展了一项以微小隐孢子虫作为免疫调节剂的免疫化疗方案的I期研究。对14名女性进行了研究。所有人均接受了剂量范围为2.5毫克至21毫克的微小隐孢子虫，通过在4小时内静脉滴注1升葡萄糖盐水中给药。未观察到肿瘤进展的迹象。
